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Abstract
Empirical evidence suggests that exposure of Americans to dioxin-like compounds was low during the early
decades of the 20th century, then increased during the 1940s and 1950s, reaching a peak in the 1960s and 1970s,
and progressively decreased to lower levels in the 1980s and 1990s. Such evidence includes dioxin analysis of
carbon-dated sediment cores of lakes and rivers, preserved meat samples from different decades of the 20th century,
and limited body burden measurements of dioxin-like compounds. Pinsky and Lorber (1998) summarized studies
measuring 2,3,7,8-TCDD in blood and adipose tissue, and found a range of 10–20 pgyg (ppt) lipid during the 1970s,
and 2–10 ppt lipid during the 1980s. This study reviews body burdens of dioxin toxic equivalents, TEQs, to find a
range from approximately 50 to 80 ppt lipid during the 1970s, 30–50 ppt lipid during the 1980s, and 10–20 ppt lipid
during the 1990s (TEQs comprised of the 17 dioxin and furan congeners only). Pinsky and Lorber (1998) investigated,
historical exposure trends for 2,3,7,8-TCDD by using a single-compartment, first-order pharmacokinetic model. The
current study extends this prior effort by modeling dioxin TEQs instead of the single compound, 2,3,7,8-TCDD.
TEQs are modeled as though they were a single compound, in contrast to an approach where the individual dioxin
and furan congeners are modeled separately. It was found that body burdens of TEQs during the 1970s, 1980s and
1990s could be modeled by assuming a historical dose which began the century at low levels of approximately 0.5
pg TEQykgyday, rose during the middle decades of the 20th century to over 6 pg TEQykgyday, and declined to
current levels of approximately 0.5 pg TEQykgyday. Trends in individual and population body burdens of TEQs are
also investigated using this PK modeling framework. A key uncertainty of this effort — assuming that TEQs behave
as though they were a single compound — is discussed and analyzed.  2002 Elsevier Science B.V. All rights
reserved.
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1. Introduction
The first evidence that exposure to dioxin-like
compounds may have been high during the middle
*Corresponding author. Tel.: q1-202-564-3243; fax: q1-
202-565-0078.
E-mail address: lorber.matthew@epa.gov (M. Lorber).
decades of the 20th century came with the analysis
of dated sediment cores of lakes and rivers (Czuc-
zwa and Hites, 1984; Czuczwa et al., 1985; Smith
et al., 1992, 1993, 1995; Alcock et al., 1997).
(The description, ‘dioxin-like compounds,’ typi-
cally includes seven polychlorinated dibenzo-p-
dioxin congeners (abbreviated PCDDs), 10
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Fig. 1. Concentrations of total dioxins and furans in dated sed-
iment cores from Beaver Lake in Washington (from Cleverly
et al., 1996).
Fig. 2. TEQ concentrations in historical meat samples (from Winters et al., 1998).
polychlorinated dibenzofuran congeners (PCDFs),
and 12 co-planar polychlorinated biphenyl conge-
ners (PCBs). This paper focuses only on the 17
PCDDyPCDF congeners.) These researchers found
low concentrations in cores dated that back hun-
dreds of years, and higher concentrations in core
segments corresponding to the 1930s through the
1960s. Higher concentrations would have resulted
from higher dioxin depositions to the land surface
and water bodies. A lake core sediment study
(Cleverly et al., 1996), comprised of cores from
11 pristine lakes around the United States, found
results which were consistent with other studies
finding higher concentrations corresponding to
these mid-century years. The results from one of
these lakes, Beaver Lake in Olympic Peninsula,
Washington, is shown in Fig. 1.
While this might be reasonable evidence of more
dioxin in the environment, it is not direct evidence
of elevated exposures. To investigate the possibility
of high past exposures, samples of preserved meat
from different decades of the 20th century were
collected and analyzed (Winters et al., 1998).
Beef, pork, and poultry samples were obtained
from such diverse sources as the USA’s National
Aeronautics and Space Agency, the National
Smithsonian Museums, Army museums which
retained soldier mess kits from as early as 1908,
and Department of Agriculture Research Labora-
tories. The results of the analysis are shown in
Fig. 2. Like the trend in sediment core studies, the
early century samples had the lowest TEQ concen-
trations, including 0.34 pg TEQyg (ppt) lipid for
the 1908 sample, 0.98 ppt lipid for the 1945
sample, with the highest concentrations at 3.01
and 3.73 ppt lipid for samples from the 1960s.
The two latest samples, both dated 1983, had
lower concentrations again at 0.50 and 0.55 ppt
lipid. Current meat concentrations of TEQs are in
the range of 0.8–1.0 ppt TEQ lipid range based
on national surveys on beef, pork, poultry, and
milk (US EPA, 2000), as displayed in Fig. 2.
Recent studies also have documented declines
in food concentrations from the 1980s to the 1990s.
Harrison et al. (1998) used data from the United
Kingdom’s Total Diet Study of 1982 and 1992 to
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show how dietary intakes of dioxin-like com-
pounds (PCDDyPCDFyPCBs) have dropped from
6.8 pg TEQykgyday to 2.4 pg TEQykgyday
between 1982 and 1992. Furst and Wilmers (1995)¨
compared the levels of dioxins and furans found
in German dairy products in 1990 with levels
collected in 1994. Over the 4-year period, the
mean TEQ concentration in milk fat decreased by
almost 25% from 1.35 to 1.02 ppt.
The Environmental Protection Agency (EPA)
reviewed this overall trend and concluded that
elevations of dioxin in the environment beginning
during the 1930s were the result of increases in
industrial and combustion practices, production
and use of phenolic compounds (e.g. pentachlo-
rophenol), and energy production (e.g. coal and
oil) (US EPA, 2000). Factors that led to the decline
in environmental levels and exposures were iden-
tified as the Clean Air Act of 1970 and associated
implementation of air pollution controls, the switch
to unleaded automobile fuels and associated use
of catalytic converters and reduction in halogenat-
ed scavenger fuel additives (remaining uses of
leaded fuel include chain saws, logging machinery,
and mowers), process changes at pulp and paper
mills, and reductions in the manufacture and use
of chlorinated phenolic intermediates and products
(such as the ban of 2,4,5-T).
Pinsky and Lorber (1998) investigated this tem-
poral trend for 2,3,7,8-tetrachlordibenzo-p-dioxin
(2,3,7,8-TCDD, hereafter referred to as TCDD)
using a single-compartment, first-order pharmaco-
kinetic model. They summarized body burden
measurements for this compound to find a range
of 10–20 ppt lipid during the 1970s, and 2–10
ppt lipid during the 1980s. Their model assumed
simplistically that all TCDD deposited into a single
body reservoir of lipids and dissipated according
to first-order kinetics. Their approach was to model
populations which were demographically similar
to the populations in these surveys. Specifically,
individuals were modeled to be born during dif-
ferent years of the 20th century. At the year of the
survey, their average predicted body burdens of
TCDD were compared to the measured TCDD
body burdens. Pinsky and Lorber assigned all but
one of the model parameters using best estimates
from the literature. Their first-order elimination
rate function for TCDD, k(t), was based on a
model developed by Michalek et al. (1996), who
modeled this parameter as a function of body fat
fraction. The one parameter not assigned values
based on the literature was a temporally varying
dose. This daily dose, in units of pg TCDDykgy
day, was ‘calibrated’ using Bayesian statistics, to
arrive at a best-fit match between predictions and
measurements of average population lipid concen-
trations of TCDD. Their best-fit dose, like the
sediment cores and preserved meat samples,
showed a steep rise from the 1940s through the
1960s, to peak at approximately 1970, and then to
decline to low constant levels starting in the 1980s.
Van der Molen et al. (1996) conducted a very
similar pharmacokinetic modeling exercise to
study the TCDD body burdens of the Dutch
population in the Netherlands. Their model was
more complicated than the one employed by Pin-
sky and Lorber (1998): it had six compartments
(blood, muscle, adipose tissue, bones, liver, and a
compartment called remaining organs), but it was
a first-order model, where the elimination of
TCDD from the body occurred at a rate that was
proportional to the TCDD concentration in the
liver. Similar to Pinsky and Lorber (1998), they
assumed that the lipid-based concentrations in each
of the compartments was equal. They found that
average body burdens of the Dutch population
could best be duplicated by assuming a temporally-
varying dose as well. Citing sediment core data,
they used a correction function, F, which was
applied to a constant intake rate and related past
intakes of TCDD to current intakes. Their F
function was bell-shaped with a peak value at 2.0
in 1965, a low value of 0.2 in 1920, and values
of 1.4 at 1980 and 0.6 in 1990.
This study is a continuance of the Pinsky and
Lorber (1998) effort, only it models TEQs as
though TEQs were a single compound. For pur-
poses of this modeling effort, a TEQ concentration
is comprised of seven PCDDs and 10 PCDFs. It
is calculated as the sum of the toxically equivalent
concentrations of each of the 17 congeners, where
this toxically equivalent concentration is calculated
as the concentration (C ) times a toxicity equiva-i
lency factor, or TEF . A TEQ concentration is,i
therefore, 8TEF C . The TEFs used to calculatei i
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the TEQ are those recommended by the World
Health Organization in 1998 (Van den Berg et al.,
1998). Dioxin-like PCBs are not included in this
analysis mainly because body burden concentra-
tions of the dioxin-like PCBs are not available.
A review of TEQ body burden literature below
is followed by a discussion of the model structure
and parameterization. Unlike the modeling of Pin-
sky and Lorber (1998), two parameters of this
model, the temporally varying dose and the rate
of dissipation of TEQs from the body, were cali-
brated. The critical assumption of modeling TEQs,
as though it were a single compound requiring
calibration, is discussed below. The modeling
framework, including the calibrations for TEQ
dose and dissipation, is then used to study trends
of exposure throughout the 20th century, and into
the 21st century.
2. Review of body burden literature for TEQs
The purpose of this section is to review dioxin
body burden monitoring studies which have been
conducted in the United States over the past few
decades. Studies which sampled either blood or
adipose tissue were compiled; studies on other
matrices such as breast milk were not included.
Lakind et al. (2000) cited several references where
measurements of breast milk concentrations of
lipophilic compounds (PCBs, DDE, DDT, PCDDy
PCDFs) were shown to decline during the course
of lactation. Therefore, breast milk may not be a
good indicator of body burden and is not included
here. Other characteristics of studies included in
this compilation are: (1) all or a toxicologically
significant subset of the 17 PCDDyPCDFs were
measured and individual-specific or overall study
average concentrations of these congeners were
available. In the few studies where less than the
17 congeners were available, it was determined
(from other studies where they were all reported
during the same time frame) that the available
congeners made up 90% or higher of the TEQ
concentration; (2) all results were reported on a
lipid basis; (3) although this was not possible for
all studies, it was desired to obtain data which had
reported detection limits so that TEQ concentra-
tions could be derived assuming non-detects
(NDs) equal one-half detection limit (1y2 DL).
When DLs were not supplied, NDs were assumed
to equal zero; (4) all measurements were on
background populations. The first study described
below included Vietnam veterans, non-Vietnam
veterans, and civilians. All three groups were
included in this analysis as the concentrations in
the three were indistinguishable; the civilian pop-
ulation had, in fact, the highest concentrations.
Another reason to include all three populations
was that this was the only study available with the
full suite of congener concentrations in the 1970s.
Two other studies (Schecter et al., 1989, 1993)
included blood samples taken from Vietnam vet-
erans only. In both of them, small subsets of
individuals appeared to have elevated concentra-
tions of TCDD and TEQs. Congener-specific aver-
ages not including these individuals could be
developed with the information in the articles, so
these amended profiles were included in this com-
pilation. (5) Only studies which sampled adult
populations were included; data on children or
infants were not included. Studies on ‘average
adult populations’, which included demographic
information, were comprised of approximately the
same number of males and females and the average
age was approximately 45. Studies on Vietnam
veterans were all male populations, and one study
sampling breast adipose tissue was on females
alone.
Twelve studies were found for this compilation.
A summary of the results from these studies is
shown in Table 1.
Only one study could be found providing con-
gener-specific concentrations from the 1970s. This
study was undertaken by the US Department of
veterans Affairs (DVA) and the EPA (Kang et al.,
1991; US EPA, 1990), and the intent was to study
tissue levels from Vietnam veterans compared to
civilians. A total of 494 potential samples were
identified from EPA’s National Human Adipose
Tissue Repository. These samples were dated from
between 1972 and 1981, and they were from males
born between 1936 and 1954. Searching military
records verified that 134 of the 494 samples were
from veterans, 40 of whom served in Vietnam.
They selected all of these 40, as well as 80 of the
remaining 94 veterans who had not served in
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Table 1
Summary of studies with body burden data of dioxins and furans
Year Mean TEQ, N Ages Reference; Location
pgyg lipid
1972 87 7 18–45 Kang et al., 1991; USEPA, 1990. Vietnam veterans,
1973 89 14 non-Vietnam veterans and Civilians.
1974 70 14
1975 68 14
1976 129 5
1977 69 17
1978 69 17
1979 67 22
1980 55 42
1981 54 26
1983 34 4 NA Schecter et al., 1986; Binghamton, NY
1985 47 35 xs43¯ Graham et al., 1986; St. Louis, MO
(21–88)
1986 31 4 xs34¯ Patterson et al., 1994; Atlanta, GA
(19–55)
1987 overall: 37 666 NA Orban et al., 1994; EPA,1991
15–44: 27.5
)45: 53.4
1988 30 26 NA Schecter et al., 1989; Massachusetts
1988 37 57 x;50¯ Stanley et al., 1989; San Francisco and Los
(12–88) Angeles, CA
1989 50 100 NA Schecter, 1991; Syracuse, NY
1991 29 44 xs48¯ Schecter et al., 1993; Michigan Vietnam veterans
(41–66)
1996 32 100 NA Schecter et al., 1997; Binghamton, NY
1996 20 316 xs45¯ Personal communication from D. Patterson,
(20–70) Center for Disease Control, Atlanta, GA, to M.
Lorber, US EPA, Washington, DC. April, 2000;
background populations from site-specific
studies in MO, OR, WS, AK and NC.
1998 25 45 xs45¯ Petreas et al. 2000; San Francisco, CA
(28–67)
Vietnam (these 80 selected randomly from the
population of 94). They matched each of the 40
veterans with two civilians in terms of age and
sex from the potential population of 494. The final
population of this study was, therefore, 200 indi-
viduals: 40 veterans serving in Vietnam, 80 non-
Vietnam veterans and 80 civilians. Five samples
were discarded as inappropriate (insufficient lipid
amounts, insufficient data regarding military stat-
us), for a final sample count of 195.
While a comprehensive set of data, this was not
a good representation of an average American
population because the oldest individual was less
than 46 years (the last year sampled, 1981, minus
the earliest birth date, 1936), and they were all
males. Still, it was the only data set from these
years that measured all the 17 PCDDyPCDFs, and
results do suggest that these individuals were not
influenced by unique high exposures. The results
from these three sample sets were indistinguishable
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— TEQ concentrations were 71.9, 65.4 and 72.0
pgyg lipid for the Vietnam veterans, the non-
Vietnam veterans, and the civilians, respectively.
The TCDD concentrations followed the same
trend, with concentrations of 13.4, 12.5 and 15.8
for the same three groups. For this reason, these
study populations were merged for further analysis
here. These full study summaries can be considered
to represent the years 1972–1981 for this limited
male population.
The results from this EPAyDVA study supplied
in US EPA (1990) did not indicate the year in
which each of the samples were taken. This infor-
mation was retrieved (by personal communication,
J. Remmers, Office of Prevention, Pesticides, and
Toxic Substances, US EPA, to M. Lorber, Office
of Research and Development, US EPA, 2000),
which allowed for the year-by-year compilations
shown in Table 1. Only 178 of the 195 samples
could be identified by year of sample collection.
As seen in Table 1, there appears to be a clear
trend, with concentrations declining from approx-
imately 80 ppt TEQ to approximately 50 ppt TEQ
between 1972 and 1981. The five samples aver-
aging 129 ppt TEQ in 1976 would appear to be
anomalous. There were other samples with con-
centrations above 100 ppt, such as a sample at
151 ppt TEQ from 1981, at 166 ppt from 1978,
and at 179 ppt from 1973, but four of the five
samples in 1976 ranged from 99 to 215 ppt TEQ.
There is no reason to believe that the high average
in 1976 is indicative of any unique exposure for
that year.
There were seven studies from the 1980s. The
most prominent study from that decade was the
National Human Adipose Tissue Survey of 1987
(NHATS ’87) (Orban et al., 1994; US EPA, 1991).
This study was undertaken, in part, to compare
with a very similarly designed survey in 1982,
NHATS ’82. For both surveys, composite samples
of adipose tissue from individuals characteristic of
average background conditions were analyzed for
the full suite of dioxin and furan congeners.
NHATS ’82 was not included in this temporal
trend compilation because there appears to have
been unexplained high findings of 1,2,3,7,8-
PCDD, and given that this congener has a TEF of
1.0, the resulting TEQ concentrations were simply
out of bounds. Specifically, this study found a
concentration of 125.0 ppt for 1,2,3,7,8-PCDD for
the age group, 15–45, and the overall average
1,2,3,7,8-PCDD concentration for NHATS ’82 at
73.6 ppt (which includes all three age groups, 0–
14, 15–45, and )45 years) is itself significantly
higher than that ever found elsewhere.
Results from 38 of the 48 composite samples
used from NHATS ’87 consisted of two age
groups: 15–45 and )45 years. The 10 composites
representing the-15 age group were not included.
These 38 samples represented 666 individuals.
According to the 1980 census, these two groups
comprised 46 and 31% of the population. Average
congener concentrations for these age groups were
weighted to get the adult average concentration of
37 ppt TEQ shown in Table 1. Like other studies,
there appears to be an age trend, with the older
set having an average of 53 ppt TEQ, while the
younger age range had an average almost half that
at 28 ppt TEQ.
Another significant study by Graham et al.
(1986) reported on the analysis of adipose tissues
from autopsy patients who were not hospitalized
but who had died suddenly or violently during
1985. They listed age and sex in the tabular
summary of results from 35 individuals. Of these
individuals, 16 were male and 19 were female,
and the age range was from 21 to 88, with an
average age of 43. The average TEQ concentration
from this population was 47 ppt lipid. There is a
clear age trend in this data set, which is examined
later in this paper, with concentrations ranging
from less than 20 ppt TEQ lipid for the youngest
sampled individual to over 100 ppt TEQ lipid for
the oldest sampled individual. The highest sample
was approximately 140 ppt TEQ lipid for a 60-
year-old individual.
Two studies, one from the 1980s and one from
the 1990s, required screening out of samples from
Vietnam veterans which were high and appear to
have been influenced by exposure to Agent
Orange. In the first study (Schecter et al., 1989),
blood was collected from 28 Vietnam veterans. Of
the 28 sampled, it appeared as though two had
been exposed to Agent Orange in Vietnam or to
another source of TCDD. The concentration of
this congener in their blood was 34 and 29 ppt
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lipid, and the TEQ concentrations were 54 and 62
ppt lipid. The other congeners in the blood of
these two individuals did not appear elevated. For
the other 26 individuals, the average TCDD con-
centration was 4.8 ppt and the average TEQ
concentration was 29.6 ppt lipid. These results
were the ones used in this compilation. In the
other study (Schecter et al., 1993), blood was
collected from 50 Vietnam veterans in 1991. Lev-
els of TCDD and other dioxins were elevated in
six of these 50 Vietnam veterans. The average
TEQ concentration in these six individuals was 85
ppt lipid. The average TEQ concentration in the
remaining individuals was much lower at 29.1 ppt
lipid. This population was used in this study.
Another study with a reasonably large popula-
tion was undertaken by the California Air
Resources Board for the purpose of determining a
preliminary estimate of the body burden levels of
dioxins and furans in the California population so
that future efforts evaluating the impact of specific
air sources can use the knowledge gained in terms
of survey design, implementation, and analysis, as
well as the background levels found (Stanley et
al., 1989). A total of 57 adipose tissue samples
were taken from an initial target population of 60
surgical patients who were in surgery for reasons
other than cancer. The average age of the patients
was approximately 50 years. The average concen-
tration found was 31 ppt. Like other studies, an
age trend was found, with a finding of -10 ppt
TEQ lipid for the youngest individuals sampled,
approximately 21 years old, to approximately 80
ppt TEQ lipid for an individual over 60 years old.
The most significant of the four studies found
representing the 1990s was supplied to the US
EPA by the Centers for Disease Control (personal
communication from D. Patterson, Center for Dis-
ease Control, Atlanta, GA, USA, to M. Lorber,
US EPA, Washington, DC, USA, April, 2000).
This extensive compilation was used by the EPA
to represent average background body burdens in
the United States during the mid- to latter 1990s
in their draft Dioxin Reassessment (US EPA,
2000). The compilation consists of results from
the background populations of six site-specific
studies: Manchester, Missouri (ns61); Times
Beach, Missouri (MO) (ns67); Jacksonville,
Arkansas (AK) (ns57); Oregon (OR) (ns9);
Wisconsin (WI) (ns93); and North Carolina
(NC) (ns29). The average TEQ concentration
from this compilation is 20 ppt lipid. The age of
the individuals sampled were available from 214
individuals located in Missouri, Arkansas, and
North Carolina. The average age was 45 years,
with a range of 20–70 years. While an age trend
is evident, which will be discussed later in the
paper, it does appear as though that the trend is
much less marked as compared to earlier years.
The most recent data available was from Petreas
et al. (2000), who presented a summary of results
of analysis of breast tissue samples taken from
women undergoing breast surgery during 1998.
Unlike the Vietnam veteran studies, this was the
only study comprised only of women. These 45
women comprised the control group in a breast
cancer case-control study in the San Francisco Bay
area. Specific results from each individual were
not available in Petreas et al. (2000), but were
supplied by personal communication (personal
communication from M. Petreas, Hazardous Mate-
rial Laboratory, California EPA, to M. Lorber, US
EPA, 2000). The average age of these women was
45, with a range of 28–67. The average TEQ
concentration was 25 ppt lipid.
Remaining studies include two studies (Schecter
et al., 1986; Patterson et al., 1994) which involved
a small number of individual samples in Bingham-
ton, NY and Atlanta, GA, a pooled sample of
blood from 100 individuals in the Syracuse, New
York Red Cross Blood Bank (Schecter, 1991), and
a second pooled (100 individuals again) blood
sample from a hospital laboratory in Binghamton,
NY (Schecter et al., 1997).
3. Pharmacokinetic modeling methods
3.1. The model
The single compartment, first-order PK model
is given by:
Ž .da t
Ž . Ž . Ž .sf D t yk t a t (1)
dt
Ž .a t
Ž .c t s (2)
Ž .1000 V t
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Fig. 3. Fraction of total body fat assumed for an individual in
the pharmacokinetic modeling (approximation of average male
and female trends, from US EPA, 1997). Fig. 4. The total body weight assumed for an individual in the
pharmacokinetic modeling (approximation of average male and
female trends, from US EPA, 1997).
Fig. 5. Three functions giving the half-life as a function of age,
including: (a) calibrated TEQ function assumed in this effort;
(b) TCDD function in Van der Molen et al. (1996); and (c)
TCDD function in Pinsky and Lorber (1998).
where a(t) is the amount of TEQ in lipid (pg)
during year t of a person’s life; c(t) is the concen-
tration of TEQ in lipid (pgyg); D(t) is the annual
exposure dose of TEQ (pgyyear), calculated as
365=e(t)=w(t) where e(t) is the daily exposure
(pg TEQykgyday) and w(t) is the body weight
(kg); V(t) is the lipid weight (kg), calculated as
the w(t)=bff(t) where bff(t) is the body fat
fraction (unitless); k(t) is the elimination rate
(years ); f is the constant fraction of dosey1
absorbed into the lipid compartment; and t
describes the year in an individual’s life (year).
The fraction absorbed, f , is the only constant in
this model, is set at 0.8, reflecting the assumption
that nearly all dioxin exposure is through animal
fat consumption and other studies have shown
high absorption by this pathway (US EPA, 2000).
Statistical data on body weight and body fat
fraction as a function of age for males and females
were averaged and used in this exercise. This data
is from EPA’s Exposure Factors Handbook (US
EPA, 1997). Figs. 3 and 4 show the assumptions
of body weight, w(t), and body fat fraction, bff(t),
as a function of a person’s age. The volume of
body lipids, V(t), is calculated as the product of
body weight and body fat fraction.
3.2. The elimination rate function for TEQs
The first-order elimination rate, k(t), was
allowed to vary as a person aged and was cali-
brated for TEQs as though they behaved as a
single compound. Fig. 5 shows three functions for
the first-order elimination rate constant, k(t), as a
function of age, including the function for TEQs
calibrated in this effort widentified as (a) in Fig.
5x, a modeled function for TCDD in Van der
Molen et al. (1998) wcurve (b)x, and a function
for TCDD that is based on a relationship between
k(t) and body fat fraction wcurve (c)x.
Pinsky and Lorber (1998) re-performed an anal-
ysis conducted by Michalek et al. (1996) and
arrived at a relationship showing that the first-
order elimination rate, k, of TCDD is a function
of body fat fraction: as body fat increases, the
elimination rate decreases (equivalently, the elim-
ination half-life increases). This analysis was con-
ducted by using blood concentration data taken
over time on Vietnam veterans with high TCDD
body burdens. This longitudinal database was
somewhat limited since it only included men and
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did not involve men with a wide age range. Still,
it demonstrated the relationship between body fat
fraction and the rate of TCDD dissipation, and
allowed for this relationship in Pinsky and Lorber
(1998):
Ž . Ž .k t sk qk F t y25 (3)Ž .0 1
where k is the elimination rate at 25% body fat0
(years ); k is a constant reflecting the changey1 1
in elimination rate with percentage body fat
(years ); and F(t) is the percentage body fat aty1
time t, which equals 100=V(t)yW(t). Pinsky and
Lorber (1998) derived estimates of 0.0775 for k0
and y0.00313 for k . For comparison, the esti-1
mates reported in Michalek et al. (1996) were
0.0665 for k and y0.00314 for k . When this0 1
relationship is combined with the body fat fraction
function shown in Fig. 4, the k(t) vs. age function
shown in Fig. 5c emerges. The Van der Molen et
al. (1998) half-life function, as shown in Fig. 5b,
was derived using an earlier toxicokinetic model
he had developed (Van der Molen et al., 1996)
and the same Vietnam veteran data. The overall
elimination rate is given as the product of a
specific elimination rate, k, and X, the ratio
between the lipid-weight of the liver and the total
body lipid-weight. In their exercise, Van der Molen
et al. (1998) developed values for all model
parameters except this specific elimination rate,
which was curve fit to this Vietnam veteran data.
The rise in their half-life function reflects the
change in X as an individual ages.
All three relationships suggest that the half-life
of these compounds increase as a person ages. For
example, the half-lives at ages 10 and 70 are 6.6
and 11.2, respectively, for TCDD according to the
relationship developed by Pinsky and Lorber
(1998), 5 and 13.8 for TCDD as developed by
Van der Molen et al. (1998), and 6.9 and 18.5 for
TEQs as calibrated in this effort.
It would have been preferable to first assign a
function to the elimination rate, k(t), for TEQs,
and then calibrate solely on the dose function, as
was done in Pinsky and Lorber (1998). However,
appropriate longitudinal data for TEQ body bur-
dens, as was available for TCDD from the Vietnam
veterans, was not available for this effort. Van der
Molen et al. (2000) located congener-specific data
on an occupationally exposed cohort who had been
exposed to high levels of dioxins and furans for a
period of several years, and had been measured
two or three times after exposure. It may be
possible at some time to use this longitudinal data
to develop congener-specific elimination rateyage
functions such as those developed for TCDD as
shown in Fig. 5. Van der Molen et al. (2000)
developed two sets of congener-specific single-
value elimination half-lives from this data — one
based on longitudinal data and the other based on
cross-sectional data, and found these two estimates
to be very similar.
Table 2 lists Van der Molen’s (2000) elimination
rates and half-lives derived for a 49-year-old per-
son, i.e. the average person from the cross-section-
al data, and the same two elimination parameters
for the 17 congeners as provided in Flesch-Janys
et al. (1996). Column 1 in Table 2 provides the
fraction that each congener provides to the overall
current intake dose of TEQ, as developed by EPA
(US EPA, 2000). For example, 10% of the current
total daily intake of TEQs is provided by TCDD.
This information can be used to derive a dose-
weighted average elimination rate andyor half-life
for a TEQ dose. This would be a first approxi-
mation suggestive of the rate that TEQs would be
eliminated. The TEQ dose-weighted half-life and
elimination rate are easily estimated as
8(Fi=HLi) and 8(Fi=Ki), where Fi are the
fractional intakes for congener i, HLi are the
congener-specific half-lives, and Ki are the con-
gener-specific elimination rates. As seen in Table
2, the TCDD half-life and elimination rate constant
appears to be approximately 7.4 years and 0.094
year , respectively, while the TEQ dose-weightedy1
terms are in the range of 9.8–12.5 years and
0.072–0.083 year . An individual half-life andy1
elimination rate are related as: HLs0.693yK.
However, the dose-weighted half-life and elimi-
nation rate are not directly related — one cannot
derive the dose-weighted half-life directly from
the dose-weighted elimination rate by this equiv-
alence:8(Fi=HLi)/0.693y8(Fi=Ki). The term
on the right hand side of this equation can also be
written as, 0.693y8wFi=(0.693yHLi)x, which is
simplified as 1y8(FiyHLi), and this is not math-
ematically equivalent to 8(Fi=HLi). This dispar-
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Table 2
Dose-weighted estimation of a first-order elimination rate for TEQs
Congener Fraction TEQ
in dosea
Flesch-Janys et al. (1996) Van Der Molen et al. (2000)
k, yeary1 half-life, years k, yeary1 half-life, years
2378-TCDD 0.1 0.096 7.2 0.091 7.6
12378-PCDD 0.33 0.044 15.7 0.062 11.1
123478-HxCDD 0.034 0.083 8.4 0.061 11.3
123678-HxCDD 0.12 0.053 13.1 0.06 11.5
123789-HxCDD 0.044 0.141 4.9 0.104 6.6
1234678-HpCDD 0.041 0.187 3.7 0.081 8.5
OCDD 0.001 0.103 6.7 0.126 5.5
2378-TCDF 0.022 0.096 7.2 0.508 1.4
12378-PCDF 0.01 0.044 15.7 0.246 2.8
23478-PCDF 0.17 0.035 19.6 0.071 9.7
123478-HxCDF 0.04 0.112 6.2 0.092 7.5
123678-HxCDF 0.035 0.116 6 0.03 23.2
123789-HxCDF 0.025 0.116 6 NA NA
234678-HxCDF 0.019 0.119 5.8 0.197 3.5
1234678-HpCDF 0.01 0.231 3 0.143 4.8
1234789-HpCDF 0.0019 0.216 3.2 0.069 10
OCDF 0 0.103 6.7 1.018 0.7
TEQ-weighted results 0.072 12.5 0.083 9.8
Defined as the fraction of the total TEQ dose that comes from each congener, from US EPA (2000).a
ity is similar to the difference between a harmonic
mean and a simple mean. Still, looked at either
way, the TEQ dose-weighted disappearance terms
imply more persistence in the body as compared
to the disappearance terms for TCDD.
Besides a lack of eliminationyage functions for
individual congeners, use of a single elimination
rate for the complex mixture of chemicals that
comprise a TEQ concentration is, strictly speaking,
invalid. For a given initial body burden of 17
PCDDyPCDF congeners, the elimination rates for
the congeners will be different such that, after
time, different profiles of the congeners will
emerge. Over time, the overall half-life of the
changing TEQ body burden profile will become
dominated by the more slowly eliminated
congeners.
This is easily demonstrated using information
provided in Table 2. The fractional terms describ-
ing the contribution of total TEQ provided by each
congener (Column 1 of Table 2) were used to
derive a hypothetical initial body burden profile of
the 17 congeners comprising a TEQ mixture. Each
congener then dissipated according to first-order
kinetics, using the Flesch-Janys half-lives provided
in the second column of Table 2. It was found that
the first half-life of this initial body burden
occurred after 11 years, and that the second half-
life (when the initial TEQ body burden was 25%
of its original concentration) 14 years later. For
this reason alone, modeling TEQs as though they
were a single compound must be thought of as a
simplification adopted here for the purposes of
modeling and better understanding past exposures
and the implications of past and present exposures
on future body burdens of TEQs.
3.3. Calibration algorithm
Individuals are modeled from birth until 70
years of age. While breast feeding can result in a
large initial increase in an infant’s body burden of
dioxin TEQs, EPA showed how the overall body
burdens of breast-fed vs. formula-fed infants begin
to merge between ages 15 and 20 (US EPA, 2000).
Therefore, predictions of average adult concentra-
tions will not be significantly affected by assump-
tions regarding exposures during infancy and
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Fig. 6. Calibrated TEQ intake dose function for this effort.
Noted is US EPA (2000) estimate of current intake dose of
0.65 pg TEQykgyday.
childhood (although lifetime exposure calculations
and other assessments are, of course, affected by
high exposures during childhood). For this exer-
cise, formula feeding is assumed, and childhood
doses of dioxins, like adult doses, are modeled as
the calibrated dose, in units of pg TEQykgyday,
times body weight, in kg.
The daily dose term for year t of an individuals
life, e(t), used for the calculation of the annual
dose term, D(t), is calibrated as was the k(t). The
calibration strategy was to have individuals born
in 5-year increments starting in 1860. Their body
burdens were modeled using a 1-year time step
until they are 70 years old. The ‘modeled’ adult
population average TEQ for a given year after
1930 (in 5-year increments, such as 1930, 1935,
etc.) was calculated as the average of TEQ con-
centrations predicted for 11 individuals, aged 20–
70, with an average age of 45.
There was no rigorous attempt to find a ‘best
fit’ of model predictions and population measure-
ments, nor was there specific attempts to match
the demographics of the measured populations.
This information was used to assist in the direction
of the calibration:
(1) The current average adult dose of TEQs as
developed by EPA is 0.65 pg TEQyg (US EPA,
2000); (2) the time of the peak dose was in the
mid to latter 1960s, which is supported by the
modeling efforts of Pinsky and Lorber (1998) and
Van der Molen et al. (1996); and (3) the TEQ
exposure at this peak might be in the range of 3–5
times higher than current exposures. This is
approximately the ratio between current and mid-
1960s meat concentrations in the historical meat
survey, and also in the range of the ‘F’ function
of Van der Molen et al. (1996). However, the peak
TCDD dose modeled by Pinsky and Lorber (1998)
is more than 20 times higher than the current dose.
Early and late century TEQ doses were set at
0.50 pg TEQykgyday. This late century assignment
is reasonably similar to the 0.65 pg TEQykgyday
background dose developed by the EPA (US EPA,
2000). There is no information on early century
and pre-20th century doses, so for the sake of
simplicity, the same constant dose of 0.50 pg
TEQykgyday was assumed. A rise in dose was
assumed to begin in 1930, to peak at 1970, and
then to decline to this constant 0.50 pg TEQykgy
day value by the end of the century. A first set of
calibration runs used the TCDD elimination rate
function shown as curve (c) in Fig. 5. It was
found, however, that the mid-century doses of
TEQs with this TCDD elimination rate had risen
to very high values, well over 10 pg TEQykgy
day, much higher than the 3:5 ratio to current dose
that seems reasonable from available data. It was
at this time that a k(t) function showing slower
elimination as the individual aged was adopted.
Then a calibrated dose rising to just above 6.0 pg
TEQykgyday was found to adequately fit the
observed data.
The following shows examples of ‘predicted’
population average concentrations. The following
11 modeled body lipid concentrations of TEQs in
pgyg lipid characterize average adult populations
in 1985 and 1995 (these were modeled using the
final calibrated and assigned model parameters):
Age™ 20 25 30 35 40 45 50 55 60 65 70 Average population
1985 26 34 40 45 48 51 54 56 59 61 63 48 pg TEQyg lipid
1995 11 14 19 23 27 30 32 35 38 40 43 28 pg TEQyg lipid
These average population predictions were com-
pared to the measured population body burdens
shown in Table 1 and described above. The final
calibrated dose function, e(t), is shown in Fig. 6.
Also identified in this figure is EPA’s estimate of
current intake of PCDDyPCDF TEQs, 0.65 pgy
kgyday (US EPA, 2000).
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Fig. 7. Predicted adult population body concentration of TEQs,
pgyg lipid (solid lines) compared against the measured popu-
lation body concentrations of TEQs, pgyg lipid (squares).
Fig. 8. Comparison of predicted (solid line with circles) and
observed body concentrations of TEQs (diamonds, from Gra-
ham et al., 1986) for the year 1985.
Fig. 9. Comparison of predicted (solid line with triangles) and
observed body concentrations of TEQs (diamonds, from Cen-
ters for Disease Control data) for the year 1995.
4. Results and discussions
Average predicted population lipid TEQ concen-
trations in 5-year increments from 1930 to 2030
were connected by the solid line shown in Fig. 7.
The observations from the 12 literature studies are
shown as dots in Fig. 7. Besides observing what
appears to be a good fit between observed and
predicted population average body lipid TEQ con-
centrations over time, no statistical goodness-of-fit
tests were conducted.
Trends in past and future exposures can be
hypothesized from this framework. For example,
Fig. 6 suggests that peak TEQ doses were above
6.0 pg TEQykgyday during the 1960s and 1970s,
which is 10 times higher than current doses recent-
ly estimated to be 0.65 pg TEQykgyday. Accord-
ing to Fig. 7, current body concentrations at
approximately 20 ppt TEQ could fall to below 10
ppt TEQ by 2020 or thereabouts assuming intakes
now stay constant at approximately 0.50 pg TEQy
kgyday.
This framework is also useful in studying trends
in population and individual body burdens. One
trend that has often been found in cross-sectional
surveys during the 1980s and 1990s is an ‘age
trend,’ that older individuals have higher body
burdens than younger individuals. Figs. 8 and 9
show individual measurements that were available
for two of the population surveys — one from
Missouri in 1985 (Graham et al., 1986) and a
subset of the Centers for Disease Control (CDC)
compilation from several sites in 1996 (personal
communication from D. Patterson, Center for Dis-
ease Control, Atlanta, GA, USA, to M. Lorber,
US EPA, Washington, DC, USA, April, 2000).
Superimposed on results for individuals in these
surveys are the modeled population prediction
corresponding to years 1985 and 1995 (these were
the 2 years demonstrated above in the calibration
section). In Fig. 8, the measured body burdens in
the St. Louis site ranged from approximately 15
to 140 pg TEQyg lipid, with an average of 47 pg
TEQyg lipid. The predicted body burdens as a
function of age appear to match this population
fairly well, with a nearly identical average of 49
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Fig. 11. Predictions of an individual’s body TEQ concentration
from ages 10 to 70 as a function of birth year.
Fig. 10. Predicted distributions of and average TEQ concentrations within an adult population for 4 years: 1965, 1985, 1995, and
2030.
pg TEQyg lipid. Fig. 9 shows a subset of the1996
CDC data set, including only those samples where
there was information on age. Of the sub-popula-
tions in the CDC compilation, individual age-
specific data was not available for the Wisconsin
data set, ns93, who had the highest average body
burden at 26 pg TEQyg lipid. The data for the
214 individuals had a smaller range and average
body burden at 18 pg TEQyg lipid. In any case,
the modeled age trend was somewhat more exag-
gerated than was measured, with a more steeply
inclining trend with age and an average of 28 pg
TEQyg lipid.
While this age trend may have been present
during the 1980s and 1990s, it may not have been
present before these dates and may not be present
in the future. Fig. 10 shows the age trend for the
year 1965 as well as the year 2030, along with the
results from 1985 and 1995. In 1965, the popula-
tion had all been experiencing the ongoing rising
high exposures, and the adult average body burden
from age 20 to 70 ranged narrowly from 72 to 78
pg TEQyg lipid. By 2030, all the population had
been experiencing the low constant dose of 0.50
pg TEQykgyday. There is a slight age trend due
to the long half-lives assumed for TEQs, but the
range is reasonably narrow from 7 to 12 pg TEQy
g lipid.
The ‘age effect’ is not necessarily a trend within
an individual, however, as seen in Fig. 11. In this
figure, the time trend in an individual’s body
burden is displayed. Body burdens are predicted
to peak during the time when doses were high,
from the 1940s to the 1970s. If that period falls
late within a persons life, e.g. those born in 1910,
then the body burdens are highest late in life, or
their body burdens could be highest earlier in life
if they were born near the end of that period.
These results suggest that individuals born around
1950 have been in a state of depuration for the
past three decades and their body burdens are
continuing to decline today.
The principal uncertainties that can be identified
for this effort include: (1) that a one-compartment,
94 M. Lorber / The Science of the Total Environment 288 (2002) 81–95
first-order model adequately describes the accu-
mulation of TEQs intakes in humans; (2) that a
TEQ body burden can be adequately modeled in
this framework with a single elimination rate
function which, in this paper, was calibrated; and
(3) that the measured body burden data collected
for this effort adequately describe the general adult
population during the 1970s, 1980s, and 1990s.
Given these uncertainties, one must be cautious in
the derivation of conclusions. Still, this framework
has been developed and used to study past, present,
and future trends in exposure of Americans to
dioxin TEQs.
Future efforts could focus on the use of more
complex physiologically-based models such as
those of Van der Molen et al. (1996) and devel-
opment of ageyelimination rate functions for indi-
vidual congeners. It might also be interesting to
locate repositories for human tissue samples in
earlier decades of the 20th century, from blood
banks, hospitals, or similar facilities, and to pos-
sibly study temporal trends in body burdens of
dioxin-like compounds more systematically.
5. Disclaimer
The views expressed in this article are those of
the author and do not necessarily reflect the views
or policies of the US Environmental Protection
Agency.
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